Literature DB >> 2087877

Liposomal vaccine: influence of antigen association on the kinetics of the humoral response.

H M Thérien1, D Lair, E Shahum.   

Abstract

The kinetics of the primary and secondary humoral responses to either encapsulated or surface-linked bovine serum albumin have been compared by measuring the production of specific total immunoglobulin, IgG and IgM at various times postimmunization. From our data it can be concluded that surface linkage is the best way to induce a rapid, intense and prolonged response which, in contrast to that induced by encapsulated BSA, is characterized by a low IgG/IgM ratio. The results are discussed in relation to the possible routes followed by the antigen depending on its mode of association with liposomes in the initiation of the humoral response. Our results suggest that liposomal vaccine may be designed to activate specific pathways of the immune network preferentially.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2087877     DOI: 10.1016/0264-410x(90)90008-a

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  The pH-sensitive fusogenic 3-methyl-glutarylated hyperbranched poly(glycidol)-conjugated liposome induces antigen-specific cellular and humoral immunity.

Authors:  Takehisa Hebishima; Eiji Yuba; Kenji Kono; Shin-Nosuke Takeshima; Yoshihiro Ito; Yoko Aida
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

Review 3.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

Review 4.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

Review 5.  Recent Advances in Subunit Vaccine Carriers.

Authors:  Abhishek Vartak; Steven J Sucheck
Journal:  Vaccines (Basel)       Date:  2016-04-19

Review 6.  Nano/microparticle Formulations for Universal Influenza Vaccines.

Authors:  Dylan A Hendy; Eva A Amouzougan; Isabella C Young; Eric M Bachelder; Kristy M Ainslie
Journal:  AAPS J       Date:  2022-01-07       Impact factor: 3.603

7.  Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators.

Authors:  Christophe Barnier-Quer; Abdelrahman Elsharkawy; Stefan Romeijn; Alexander Kros; Wim Jiskoot
Journal:  Pharmaceutics       Date:  2013-07-25       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.